Connect with us

Health

UTHSC receives $1.25 million to conduct a study on improving adherence to HPV vaccine – News-Medical.Net

The human papillomavirus (HPV) vaccine was introduced in the United States for preteens more than a dozen years ago, yet adherence rates are still below those for…

Published

on

The human papillomavirus (HPV) vaccine was introduced in the United States for preteens more than a dozen years ago, yet adherence rates are still below those for other childhood vaccines. Researchers at the University of Tennessee Health Science Center and Emory University have received a major grant totaling $2.7 million from the National Cancer Institute/National Institutes of Health to conduct a five-year study aimed at developing methods to improve adherence to the HPV vaccine. UTHSC will receive…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending